NCT05259826

Brief Summary

Aim of the study is to improve the diagnosis of food allergy and hypersensitivity. Intestinal homogenates will be used to determine total IgE, specific IgE, tryptase, histamine and inflammation parameters (IFNgamma, TNFalpha). These data will be correlated with serum values and disease status. In addition, organoids from duodenal tissue will be isolated and cultured in vitro and stimulated with the major food allergens. The gene and protein expression will be checked to identify relevant biomarkers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
115

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 2, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2025

Completed
Last Updated

July 5, 2024

Status Verified

July 1, 2024

Enrollment Period

3 years

First QC Date

February 18, 2022

Last Update Submit

July 3, 2024

Conditions

Keywords

mucosal IgEinflammation parameter

Outcome Measures

Primary Outcomes (1)

  • Determination of mucosal IgE to identify patients with gastrointestinal food allergy

    Homogenates of mucosal biopsies will be checked for IgE levels

    3 years

Secondary Outcomes (2)

  • Identification of patients with food hypersensitivity

    3 years

  • Correlation of mucosal IgE and inflammatory parameters with data from organoids

    3 years

Study Arms (2)

patients with food hypersensitivity

EXPERIMENTAL
Other: biopsy sampling

healthy controls

EXPERIMENTAL
Other: biopsy sampling

Interventions

1. Biopsies are homogenised in buffer and used for the determination of mucosal IgE and inflammatory parameters. 2. Biopsies are used to isolate organoids, stimulate them with blood cells and food antigens and to study gene and protein expression.

healthy controlspatients with food hypersensitivity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • informed consent
  • patients with suspected food allergy or hypersensitivity

You may not qualify if:

  • pregnant person

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg

Erlangen, 91052, Germany

RECRUITING

MeSH Terms

Conditions

Food Hypersensitivity

Interventions

Chorionic Villi Sampling

Condition Hierarchy (Ancestors)

Hypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

BiopsyCytodiagnosisCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisSpecimen HandlingPrenatal DiagnosisDiagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques, SurgicalSurgical Procedures, OperativeInvestigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Data derived from patients with food hypersensitivity will be compared with data of healthy controls
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Dr.

Study Record Dates

First Submitted

February 18, 2022

First Posted

March 2, 2022

Study Start

February 1, 2022

Primary Completion

January 31, 2025

Study Completion

January 31, 2025

Last Updated

July 5, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations